As always, the medication issue is way more complicated than a lot of people think. And this Washington Post article—"Debate over Drugs for ADHD Reignites"—illustrates that. Do ADD meds offer long-term benefits for children? Even the researchers collaborating on a major study are squabbling about it. There's a lot to learn from their debate as laid out in the article.
Psychologist John M. Grohol brings up an interesting point in a related blog post at PsychCentral: Maybe medication decisions shouldn't be so much about whether to use meds, but also about how to sequence different treatments—possibly including meds—in the best way.
And Grohol links to a post on health-care finance expert Maggie Mahar's blog about the big picture of research, money, politics, and ADD meds, with an interesting look at the issue from an international standpoint. It's a balanced and informed piece.
I've added another post on the complexity of medication, "It's Complicated Redux."